TrialMolecular pain2022

Human safety study of a selective neuronal adenylate cyclase 1 inhibitor NB001 which relieves the neuropathic pain and blocks ACC in adult mice.

Weicong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.